Anal cancer: The end of the road for neoadjuvant chemoradiotherapy?

Journal of Clinical Oncology

Volumn 26, Issue 22, 2008, Pages 3669-3671

  Glynne Jones, Rob ^a   Mawdsley, Suzy ^a  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CETUXIMAB; CISPLATIN; FLUOROURACIL; MITOMYCIN; OXALIPLATIN; TAXANE DERIVATIVE; ANTINEOPLASTIC AGENT;

ADD ON THERAPY; ADJUVANT CHEMOTHERAPY; ANUS CARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL TRIAL; COLOSTOMY; FOLLOW UP; HUMAN; LYMPH NODE; MULTIPLE CYCLE TREATMENT; NOTE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; TREATMENT FAILURE; ADJUVANT THERAPY; ANUS TUMOR; MORTALITY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FLUOROURACIL; HUMANS; MITOMYCIN; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 49249135763     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.18.1651     Document Type: Note

References (16)

1. Ajani JA, Winter KA, Gunderson LL, et al: Fluorouracil, mitomycin and radiotherapy vs fluorouracil, cisplatin and radiotherapy for carcinoma of the anal canal: A randomised controlled trial. JAMA 299:1914-1921, 2008
2. Peiffert D, Giovannini M, Ducreux M, et al: High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal carcinoma: Final results of a phase II study. Ann Oncol 12:397-404, 2001
3. Meropol NJ, Niedzwiecki D, Shank B, et al: Combined-modality therapy of poor prognosis anal canal carcinoma: A phase II study of Cancer and Leukemia Group B (CALGB). Proceedings of the ASCO Gastrointestinal Symposium, American Society of Clinical Oncology, Alexandria, VA, 2005 (abstr 238)
4. James R, Meadows H, Wan S: ACT II: The second UK phase III anal cancer trial. Clin Oncol (R Coll Radiol) 17:364-366, 2005
5. James R, Meadows HM: The second UK phase III anal cancer trial of chemoradiation and maintenance therapy (ACT II): Preliminary results on toxicity and outcome. Proc Am Soc Clin Oncol 22:287, 2003 (abstr 1151)
6. Glynne-Jones R, Hoskin P: Neoadjuvant cisplatin chemotherapy before chemoradiation: A flawed paradigm? J Clin Oncol 25:5281-5286, 2007
7. Bartelink H, Roelofsen F, Eschwege F, et al: Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040-2049, 1997
8. UKCCCR Anal Cancer Working Party: Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil and mitomycin c. Lancet 348:1049-1054, 1996
9. Flam M, John M, Pajak TF, et al: Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized Intergroup study. J Clin Oncol 14:2527-2539, 1996
10. John M, Flam M, Berkley B, et al: Five year results and analyses of a phase III randomised RTOG/ECOG chemoradiation protocol for anal cancer. Proc Am Soc Clin Oncol 17, 1998 (abstr 989)
11. Vermorken JB, Remenar E, van Heren C, et al: Cisplatin, fluorouracil and docetaxel in unresectable head and neck cancer. N Engl J Med 357:1695-1704, 2007
12. Posner MR, Hershock DM, Blajman CR, et al: Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357:1705-1715, 2007
13. John M, Pajak I, Flam M, et al: Dose escalation in chemoradiation for anal cancer: Preliminary results of RTOG 9208. Cancer J Sci Am 2:2205-2211, 1996
14. Crehange G, Bosset M, Lorchel F, et al: Combining cisplatin and mitomycin with radiotherapy in anal carcinoma. Dis Colon Rectum 50:43-49, 2007
15. Peiffert D, Gerard JP, Ducreux M, et al: Induction chemotherapy (ICT) and dose intensification of the radiation boost in locally advanced anal cancer (LAACC): Interim analysis of the 101 first randomised patients (pts) in the Intergroup ACCORD 03 trial (Federation Nacionale des Centres de Lutte Contre le Cancer-Fondation Francaise de Cancerologie Digestive). Eur J Cancer 2:172, 2005 (suppl 3; abstr 614)
16. Martenson S, Lipsitz H, Wagner et al: Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): An Eastern Cooperative Oncology Group study. Int J Radiat Oncol Biol Phys 35:745-749, 1996